IGF-1-induced epithelial-mesenchymal transition in MCF-7 cells is mediated by MUC1

Cellular Signalling

Volumn 26, Issue 10, 2014, Pages 2131-2137

  Liao, Gaoyong ^a,b   Wang, Mengyu ^b   Ou, Yu ^a   Zhao, Yong ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Simcere Pharmaceutical Co Ltd ^*  (China)

Author keywords

EMT; ERK; IGF 1; Migration; MUC1; PI3K Akt

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MUCIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; BETA CATENIN; CADHERIN; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; NITRILE; SMALL INTERFERING RNA; VIMENTIN;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MCF 7 CELL LINE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

BETA CATENIN; BUTADIENES; CADHERINS; CELL MOVEMENT; CHROMONES; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MCF-7 CELLS; MORPHOLINES; MUCIN-1; NITRILES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VIMENTIN;

EID: 84904419603     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.06.004     Document Type: Article

References (36)

1. Valastyan S., Weinberg R.A. Cell 2011, 147:275-292.
2. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Cell 2009, 139:871-890.
3. Said N.A., Williams E.D. Cells Tissues Organs 2011, 193:85-97.
4. Baserga R., Peruzzi F., Reiss K. Int. J. Cancer 2003, 107:873-877.
5. All-Ericsson C., Girnita L., Seregard S., Bartolazzi A., Jager M.J., Larsson O. Invest. Ophthalmol. Vis. Sci. 2002, 43:1-8.
6. Walsh L.A., Damjanovski S. Cell Commun. Signal. 2011, 9:10.
7. Shimizu C., Hasegawa T., Tani Y., Takahashi F., Takeuchi M., Watanabe T., Ando M., Katsumata N., Fujiwara Y. Hum. Pathol. 2004, 35:1537-1542.
8. Gombos A., Metzger-Filho O., Dal Lago L., Awada-Hussein A. Investig. New Drugs 2012, 30:2433-2442.
9. Dunn S.E., Ehrlich M., Sharp N.J., Reiss K., Solomon G., Hawkins R., Baserga R., Barrett J.C. Cancer Res. 1998, 58:3353-3361.
10. Long L., Rubin R., Baserga R., Brodt P. Cancer Res. 1995, 55:1006-1009.
11. Kufe D.W. Nat. Rev. Cancer 2009, 9:874-885.
12. Regimbald L.H., Pilarski L.M., Longenecker B.M., Reddish M.A., Zimmermann G., Hugh J.C. Cancer Res. 1996, 56:4244-4249.
13. Ciborowski P., Finn O.J. Clin. Exp. Metastasis 2002, 19:339-345.
14. Shen Q., Rahn J.J., Zhang J., Gunasekera N., Sun X., Shaw A.R., Hendzel M.J., Hoffman P., Bernier A., Hugh J.C. Mol. Cancer Res. 2008, 6:555-567.
15. Rahn J.J., Chow J.W., Horne G.J., Mah B.K., Emerman J.T., Hoffman P., Hugh J.C. Clin. Exp. Metastasis 2005, 22:475-483.
16. Horm T.M., Schroeder J.A. Cell Adhes. Migr. 2013, 7:187-198.
17. Kufe D.W. Oncogene 2013, 32:1073-1081.
18. Albrecht H., Carraway K.L. Cancer Biother. Radiopharm. 2011, 26:261-271.
19. Li Y., Yi H., Yao Y., Liao X., Xie Y., Yang J., Yan Z., Wang L., Lu S., Kuang Y., Gu M., Fei J., Wang Z., Huang L. PLoS One 2011, 6:e19102.
20. Schroeder J.A., Adriance M.C., Thompson M.C., Camenisch T.D., Gendler S.J. Oncogene 2003, 22:1324-1332.
21. Aubert S., Fauquette V., Hemon B., Lepoivre R., Briez N., Bernard D., Van Seuningen I., Leroy X., Perrais M. Cancer Res. 2009, 69:5707-5715.
22. Mikami Y., Hisatsune A., Tashiro T., Isohama Y., Katsuki H. Biochem. Biophys. Res. Commun. 2009, 379:1060-1065.
23. Khodarev N., Ahmad R., Rajabi H., Pitroda S., Kufe T., McClary C., Joshi M.D., MacDermed D., Weichselbaum R., Kufe D. Oncogene 2010, 29:920-929.
24. Pochampalli M.R., Bejjani R.M.e., Schroeder J.A. Oncogene 2006, 26:1693-1701.
25. Li Y., Kuwahara H., Ren J., Wen G., Kufe D. J. Biol. Chem. 2001, 276:6061-6064.
26. Rajabi H., Joshi M.D., Jin C., Ahmad R., Kufe D. Prostate 2011, 71:1299-1308.
27. Lacunza E., Baudis M., Colussi A.G., Segal-Eiras A., Croce M.V., Abba M.C. Cancer Genet. Cytogenet. 2010, 201:102-110.
28. Rajabi H., Jin C., Ahmad R., McClary C., Joshi M.D., Kufe D. Genes Cancer 2010, 1:62-68.
29. Sachdeva M., Mo Y.Y. Am. J. Transl. Res. 2010, 2:170-180.
30. Siddle K. J. Mol. Endocrinol. 2011, 47:R1-R10.
31. Kufe D.W. Oncogene 2012, 32:1073-1081.
32. Gleizes P.E., Munger J.S., Nunes I., Harpel J.G., Mazzieri R., Noguera I., Rifkin D.B. Stem Cells 1997, 15:190-197.
33. Chen J., Wu A., Sun H., Drakas R., Garofalo C., Cascio S., Surmacz E., Baserga R. J. Biol. Chem. 2005, 280:29912-29920.
34. Yamamoto M., Bharti A., Li Y., Kufe D. J. Biol. Chem. 1997, 272:12492-12494.
35. Schroeder J.A., Masri A.A., Adriance M.C., Tessier J.C., Kotlarczyk K.L., Thompson M.C., Gendler S.J. Oncogene 2004, 23:5739-5747.
36. Saxena N.K., Taliaferro-Smith L., Knight B.B., Merlin D., Anania F.A., O'Regan R.M., Sharma D. Cancer Res. 2008, 68:9712-9722.